Clinical Trial Update: The Effect of Oral Clostridium Butyricum on the Recurrence After Colonoscopic Resection of Colorectal Adenoma [Phase 4]

View source ↗

Summary

This clinical trial is a Phase 4 study evaluating oral Clostridium butyricum for reducing recurrence after colonoscopic resection of colorectal adenoma; it is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Adenoma

Drugs mentioned

• Clostridium butyricum (Clostridium butyricum)

Snippet

Sponsor: The Affiliated Hospital of Qingdao University | Conditions: Colorectal Adenoma, Probiotics | Phase 4 | Status: NOT_YET_RECRUITING